chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a pharmacist and described the occurrence of anaphylaxis in a subject of unspecified age and gender who was vaccinated with DTAP (manufacturer unspecified), IPV, and MMR.  The subject's medical history and concurrent medications were not provided.  On an unspecified date the subject received an unspecified dose of DTAP (unknown), an unspecified date the subject received an unspecified dose of DTAP (unknown), an unspecified dose of IPV, and an unspecified dose of MMR vaccine.  At an unspecified time after vaccination with DTAP, IPV and MMR vaccine, the subject experienced anaphylaxis that required an emergency department visit.  The pharmacist considered the event was clinically significant (or requiring intervention).  At the time of reporting the outcome of the event was unspecified.
12/7/21 Pt is a 32 yr/o who presents to the ED complaining of fatigue, myalgias, mild HA, nausea, vomiting and loss of appetite for 3 days. Pt has covid and is concerned about her pregnancy.  She denies any cough, congestion, dyspnea, chest pain, palpitations, hematemesis, diarrhea, constipation, hematochezia, melena, vaginal bleeding, vaginal discharge or abdominal pain.  She does report being exposed to Covid and she is currently 27 weeks pregnant.  She does not have any medications at home for nausea and has not contacted her OB/GYN today but was seen in the office yesterday.  She does not believe she has lost taste or smell but states that throughout her pregnancy she has had alteration in taste and intermittent
Persistent worsening pain in shoulder and upper arm. Unable rotate arm at shoulder or lift more than 90° or higher than shoulder.  Feels like a frozen shoulder.  Arm begins to shake if I try to u2se strength.
pt recvd vax;arm is sore,swollen,slightly red;itched x 2 days p/ shot;advised to apply heat,warm/wet compress & take apap for pain;still swollen 19jan95;
PATIENT BEGAN HAVING DIFFICULTY BREATHING.   MOM TOOK HER TO THE ER AND WAS TERATED AND RELEASED.
red scaly rash on torso. seemed to clear up then came back & spread on torso - has become itchy.
Felt "hot" then noticed rash on right arm, then R arm. Started out as a small "whelp" then started peeling, scabbed over around 9-23-14? Self treatment with neosporin. Pt came into H. Dept on 9-24-14 due to nurse at school sent child home due to rash. I noted 2 spots on right arm and 3 spots on left arm. Scabbed over. One spot on right arm was healed, but discolored the skin in area of injection. After discussion with Program Manager advised patient and mother to go see MD. Called patient mother today. She stated, took child to ER. MD stated per mother related to the TDAP injection. Continue with neosporin. Child back in school.
Approximately 10-11 hours after receiving the vaccine injection I developed severe flu like symptoms.  I developed a fever of 102 F, a headache, chills and severe joint and muscle pain.  The majority of the symptoms resolved within 36 hours of onset but I am still experience severe joint and muscle pains, headaches, fatique/exhaustion and difficulty thinking clearly.
I received both doses of the Pfizer vaccine in January and early February and in June I started having serious allergic reactions shortly after eating. This happened multiple times with different symptoms starting with a rash on my neck and then later my throat starting to close. I then went to an allergist to find out what the allergen was. The scratch test on my back was negative but the blood test showed I was allergic to shrimp, but not any other shellfish. I have had shrimp throughout my life with no problem until now.
Tired, weak, stomach ache, and vomiting.  Got better later on 11/09/2009, Monday.
Pt. returned to office at 4:00 pm- with red spotty rash on facial area.  No c/o itching voiced.  No rash noted on trunk at time of visit.  VS obtained, normal.  No distress, Advised pt to take BENADRYL.
Hives on face, neck and chest.  Itching all over.  Eyes swollen.  No swelling of tongue or throat.
She began having hives (uritcaria) one week after first dose of vaccine. It was assumed that terbinafine caused hives, so these were stopped. She got second vaccine on 2/2/21 and had a spreading of the hives. No angioedema or SOB, wheezing, and no anaphylaxis symptoms occured.
Pt. called and complained of severe lightheadedness & dizziness for over 24 hrs.
Hive, burning, itching, redness, warmth in L arm from site of injection (L Deltoid) to L FA.
This spontaneous report was received from a pharmacist concerning a patient of unknown gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On 16-APR-2017, the patient was vaccinated with an improperly stored dose of ZOSTAVAX 19400 plaque forming units, lot # M037013, expiration date: 22-NOV-2017, as prophylaxis (Dose and route were not reported), which experienced a temperature excursion of 15 to 46 Fahrenheit degrees for 12 hours. There were no previous temperature excursions and a digital data logger was involved. No adverse effects were reported. The patient's concomitant medications included sterile diluent. This is one of 4 reports received from the same reporter. Sender's Comments: US-009507513-1707USA009283: US-009507513-1707USA009292: US-009507513-1707USA009294.
CHILLS; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 12-APR-2021 13:00, the subject experienced chills. On 12-APR-2021 13:00, the subject experienced headache.  Laboratory data (dates unspecified) included: COVID-19 virus test negative (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, and headache. This report was non-serious.
INJECTION SITE PAIN, NECK PAIN, BODY ACHES, RIGHT KNUCKLE PAIN Narrative:
Patient received KINRIX (DTap and IPV) to left medial thigh and Flu to left lateral thigh 2/6/09. Mother noticed itching, redness and swelling at medial left thigh evening of 2/8/09. No hives/other rash or other sx. Measuring 20.5cmx14cm.
Headache, Myalgia, Arthralgia, hx of Sickle cell  Narrative:
Had the shots and still got shingles/ Suspected vaccination failure; Shingles; Painful; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had the shots and still got shingles/ Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles) and pain (Verbatim: Painful). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not reported.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 24-MAR-2023 This case was reported by patient via interactive digital media. The patient reported that he or she received shingles vaccine and experienced shingles and it was most painful thing that he or she ever deal with. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory details were unknown at a time of reporting. The follow-up could not be possible as the as no contact details were available.
I took the booster shot now; I took the booster shot now; the creatinine level of the Kidney number got increased by 25% got worse; got worse; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number was not reported, number, Expiration date: unknown), dose 3 via an unspecified route of administration on an unspecified date as dose 3 (booster), single and dose 2 via an unspecified route of administration on an unspecified date (, Lot number was not reported, UPC, NDC number, Expiration date: unknown) as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Lot number was not reported, Expiration date was unknown) as dose 1, single for COVID-19 immunization. On an unspecified date, the patient took the Pfizer shot first and second shot and after the second shot the creatinine level of the Kidney number got increased by 25% got worse and then it got better after a month or two. Patient took the booster shot and the booster shot brought up the creatinine number 25% again. On an unspecified date, the patient underwent lab tests and procedures which included creatinine: 25 % (Increased). The outcome of the events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained. No further information is expected.
Patient received vaccine 2 days in a row/Vaccine administered not waiting 28 days; Received three doses of Moderna covid-19; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (Received three doses of Moderna covid-19) and MEDICATION ERROR (Patient received vaccine 2 days in a row/Vaccine administered not waiting 28 days) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A, 026L20A and 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Psychiatric disorder NOS.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced EXTRA DOSE ADMINISTERED (Received three doses of Moderna covid-19). On an unknown date, the patient experienced MEDICATION ERROR (Patient received vaccine 2 days in a row/Vaccine administered not waiting 28 days). On 10-Feb-2021, EXTRA DOSE ADMINISTERED (Received three doses of Moderna covid-19) had resolved. At the time of the report, MEDICATION ERROR (Patient received vaccine 2 days in a row/Vaccine administered not waiting 28 days) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No  concomitant medical  provided by the reporter. No treatment medication provided by the reporter. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine)  was Not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: Follow-up received on 12-APR-2021 and contains no new information.; Reporter's Comments: This report refers to a case of extra dose administered for mRNA-1273 with no associated AEs.
Pt admitted to a local health care facility with a positive COVID test and influenza induced SARs pneumonia; hypoxic respiratory failure; started on O2, Tamiflu, Decadron, Remdesivir; pt failed to improve; ABX given; mental status deteriorated; pt began to aspirate with eating; family opted for hospice care in SNF; dc'd to an Assisted Living facility where he passed away
Pt came into office on 3/6/00 with rash in 3 stages all over body. Described as an itchy rash  with papules, vesicles and scabs. Treated with Benadryl and instructed on signs of infection.
Rash-swollen-painful-hot-hard-red even after more than 50 hours post injection. Also fever, chills, lethargy.
Patient given Zostavax (Shingles) vaccine instead of needed Varicella (Chickenpox) vaccine.
Pt received vaccine son Wednesday. Thurs. his parent reported that he had (L) arm swelling, itching, and pain at injection site. No N&V, no fever, no constitutional sxs.
Second shot is what caused side effects that were equal to my MS symptoms when diagnosed in 1998...extreme nerve pain and muscle spasms. I decided to have this vaccine since I had a mild case of shingles a couple of years ago and was told this was NOT a live virus. Further study needs to be done on any person with MS or any other neurological disease. I had the listed side effects but to the extreme along with spasms, etc.  I would not recommend to anyone who had a more severe case of MS. Should report to National MS Society. The first shot was mild but this second one is awful.  It will be interesting to see how long it takes to recover. Have contacted my physician with this information.  No follow up at this time but it is still early.
Severe headache developed about 30min after administration. Relieved by sleep. Almost exactly 24hours later, around 2pm the day after administration, developed severe occipital h/a again with radiation down into neck. Mild chills, body aches, fatigue, and tachycardia about 28 hours after administration - duration about 5 hours. Again, around 2pm the second day after administration, developed the same occipital h/a and neck pain/stiffness as well as mild tachycardia.
This spontaneous report as received from a vaccine coordinator refers to a 5-year-old male patient. The patient's medical history was not reported. On 08-JAN-2018, the patient was vaccinated with improperly stored PROQUAD therapy type RHA, lot # N023001, expiration date 19-FEB-2019 or lot # N019249, expiration date 20-DEC-2018 for prophylaxis (dose, route and site of administration were not reported). The vaccine underwent a temperature excursion of 20 degrees Fahrenheit for 1 hour and 42 minutes. Other temperature excursions were: 6 degrees Fahrenheit for 48 minutes, 18 degrees Fahrenheit for 1 hour and 5 minutes and 8 degrees Fahrenheit for 1 minute. Digital data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1801USA013248: US-009507513-1802USA005175: US-009507513-1802USA005176: US-009507513-1802USA005177: US-009507513-1802USA005178: US-009507513-1802USA005179.
pt recv vax tested positive for two viruses known as HTLV-1 & HTLV-2 commonly known as HIV;repeated testing by an infect disease specialist determined pt did not have these two viruses;pt claims suffered loss of ability to work;
The patient experienced nausea and dizzines immediately after the vaccination  while sitting on the chair . No fall or injury happened. Patient was monitored for 25-30 minutes before leaving the building with his friend.
A report has been received from a Health Professional concerning a 3 year old, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 02-Dec-2014. Ir as reported that patient ws administered by expired FLUMIST which started on 02-dec-2014. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
Initial report received from a consumer, who is also the patient's parent, on 02 October 2014. This case pertains to an infant patient who received transplacental ADACEL; information for the maternal case can be found in 2014SA137657. A male patient received a transplacental dose of ADACEL (lot number and administration details not reported) in February 2013. Prior to her vaccination, his mother had a history of pertussis while pregnant; after vaccination she developed preeclampsia for the last five months of her pregnancy. Per the reporter, the patient's delivery was difficult. At four days of age, the patient experienced seizures, which the reporter attributed to an electrolyte imbalance due to preeclampsia. He began experiencing poor eye contact and did not want to be held. Between four and nine months of age he was meeting his developmental milestones, but after that time milestones were not met. He was not talking, and did not clap, point, or wave. According to the reporter the patient had been diagnosed with PNOS autism spectrum. Outcome was not reported. Documents held by sender: None.
Extreme pressure in her head; Hard to open eyes; Fatigue/extremely tired; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 30-Mar-2021 and was forwarded to Moderna on 30-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (Extreme pressure in her head), EYE MOVEMENT DISORDER (Hard to open eyes) and FATIGUE (Fatigue/extremely tired) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included PRAVASTATIN, ACETYLSALICYLIC ACID (ASPIRIN LOW), CALCIUM and DENOSUMAB (PROLIA) for an unknown indication.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced HEAD DISCOMFORT (Extreme pressure in her head) and EYE MOVEMENT DISORDER (Hard to open eyes). 17-Mar-2021, the patient experienced FATIGUE (Fatigue/extremely tired). The patient was treated with PARACETAMOL (TYLENOL) for Head discomfort, Fatigue and Eye movement disorder, at an unspecified dose and frequency. At the time of the report, HEAD DISCOMFORT (Extreme pressure in her head), EYE MOVEMENT DISORDER (Hard to open eyes) and FATIGUE (Fatigue/extremely tired) outcome was unknown. Not Provided          Reportedly, the patient was asymptomatic following treatment with Tylenol.   This case was linked to US-MODERNATX, INC.-MOD-2021-062608 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-062608:Case for first dose
your vaccines (Unspecified vaccines) for your corona virus killed my grandmother and father; killed my family members; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "your vaccines (Unspecified vaccines) for your corona virus killed my grandmother and father; killed my family members". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300073481 same product and event, different patient;; Reported Cause(s) of Death: your vaccines (Unspecified vaccines) for your corona virus killed my grandmother and father; killed my family members
Nausea, lightheaded, sore arm, fatigue. Pt reported had soreness, fatigue and chills after first dose on 8/26/15. Sxs more severe after 2nd dose given.
Pt has a red and swollen area on her left shoulder it is warm. She also is having some nausea.
Sore Armpit (Injected Arm); Sore breast on movement; Sore Shoulder (Injected Arm); This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Sore Armpit (Injected Arm)), BREAST PAIN (Sore breast on movement) and ARTHRALGIA (Sore Shoulder (Injected Arm)) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced AXILLARY PAIN (Sore Armpit (Injected Arm)), BREAST PAIN (Sore breast on movement) and ARTHRALGIA (Sore Shoulder (Injected Arm)). At the time of the report, AXILLARY PAIN (Sore Armpit (Injected Arm)), BREAST PAIN (Sore breast on movement) and ARTHRALGIA (Sore Shoulder (Injected Arm)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were given No treatment information was provided
chills; really high fever of 102; body aches; headache; feels like she has the flu; eyes burning; body shakes; feeling nauseated; This is a spontaneous report from a contactable consumer (patient) received via medical information team. A 33-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 04May2021 12:00 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced chills, really high fever of 102, body aches, headache, feels like she has the flu, eyes burning, body shakes and feeling nauseated at 12 midnight (05May2021). The patient stated 'it feels like someone was sitting on her'. The patient reported that the fever was constant and it was 101 at the time of the report (05May2021). Patient asked if she could take Tylenol. Outcome of the event fever was not resolved and outcome of remaining events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
On 3/7/2020 the patient visited the pharmacy to pick up her prescriptions at that time the pat stated that she had received both shots of Shingrix.  She stated that she experienced no problems after receiving her first dose, but after receiving her second dose ( on 2/22/2020) she felt some discomfort.  During a routine medical appt. after receiving her second shot she dioscussed with her MD, after assessment the MD acknowledge the reaction and advised that she inform the pharmacy.  When asked if any medications were prescribed by her MD the pt informed that they had not.  The pt then stated that since visitng her MD she noticed red marks on her skin, close to the injections site and also pain in the foream when rotating her wrist.  This writer advised that she should inform her MD of her new sympotoms and if they worsen seek medical care immediately.  Pt mentioned no other symptoms.
Had given patient second COVID vaccine with consent. Patient tolerated well. I was notified on 10-31-22 that the vaccine was actually expired when I had given to patient, per Pfizer it was a short dated vaccine. I notified patient's guardian of incident, guardian was understanding of situation and verbalized understanding.
Hospitalized with COVID+ testing on 8/19, initially to observation, then flipped to inpatient STATUS.
2 days after the vaccine I developed a rash around the injection site 2/6/2021. After three days the rash was gone without treatment. Then on 2/14/2021 I started feeling burning  pain all over my neck and chest. It was slightly red that night. The next morning my chest, neck, and upper back had a red rash . My chest was the worst of it. Felt like a chemical burn . I went to the Doctor on 2/17/2021 and was told it was a delayed hypersensitivity reaction to the vaccine. I continued to take Benadryl, Zyrtec  and was given Kenalog. On Sunday 2/21/2021 the pain was so pain and the rash was only getting worse and now on my face so I went to urgent care. There I was given a steroid ( prednisone) , derma smoothe and Pepcid. It has been 10 days and no improvement yet.